Full-Time
Develops insulin delivery systems for diabetes
$34 - $51.25/hr
Acton, MA, USA
Hybrid
Requires on-site work from an Insulet office at least 3x/week.
🧬Biology & Biotech (1) |
---|
Insulet Corporation develops and manufactures insulin delivery systems specifically for individuals with diabetes. Its main product, the Omnipod, is a tubeless and waterproof insulin pump that allows for continuous insulin infusion under the skin. This system is designed to be more convenient and discreet compared to traditional insulin pumps that use tubing, making diabetes management easier for users. Insulet operates globally, with its headquarters in Acton, Massachusetts, and various manufacturing facilities around the world. The company focuses on selling the Omnipod system, which includes disposable pods and a personal diabetes manager (PDM). Insulet targets people with insulin-dependent diabetes who prefer a flexible and user-friendly method of insulin delivery. The company is also advancing its product offerings, such as the Omnipod 5, which features automated insulin delivery that works with continuous glucose monitors.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Acton, Massachusetts
Founded
2000
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
It goes without saying that Insulet was not just the winner of ADA 2025 it won by a landslide.
Insulet (NasdaqGS:PODD) launches Omnipod 5 iPhone App with Dexcom G7 compatibility - Simply Wall St news.
Insulet has launched a humorous paid social campaign for its wearable Omnipod 5 insulin delivery system - and teamed with Marvel for a stigma-busting comic book starring a teen heroine with diabetes.
Insulet Corp. (PODD), a medical device company, on Monday announced that Chief Executive Officer Jim Hollingshead has resigned from the Board of Directors.
Ashley McEvoy has been tapped to be president and CEO of Insulet.